|
Volumn 130, Issue 12, 2012, Pages 1612-1613
|
Use of autologous serum eyedrops for the treatment of ocular surface disease: First US experience in a large population as an insurance-covered benefit
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AUTOLOGOUS SERUM EYE DROPS;
EYE DROPS;
STEROID;
UNCLASSIFIED DRUG;
ADULT;
AGED;
ARTICLE;
DRUG INDICATION;
DRY EYE;
FEMALE;
FOLLOW UP;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
MEDICAL RECORD REVIEW;
OCULAR SURFACE DISEASE;
PRIORITY JOURNAL;
RETROSPECTIVE STUDY;
SJOEGREN SYNDROME;
STEVENS JOHNSON SYNDROME;
TREATMENT DURATION;
UNITED STATES;
AGED;
BLOOD TRANSFUSION, AUTOLOGOUS;
EYE DISEASES;
FEMALE;
HUMANS;
INSURANCE BENEFITS;
MALE;
OPHTHALMIC SOLUTIONS;
RETROSPECTIVE STUDIES;
UNITED STATES;
|
EID: 84871254310
PISSN: 00039950
EISSN: 15383601
Source Type: Journal
DOI: 10.1001/archophthalmol.2012.1652 Document Type: Article |
Times cited : (15)
|
References (6)
|